Follicular Lymphoma | Tumor

FDA Grants Lunsumio Priority Review for Relapsed/Refractory Follicular Lymphoma

July 7th 2022, 3:00pm

Article

The priority review comes following positive clinical trial results, which may lead to a shift in the treatment paradigm for follicular lymphoma, according to an expert.

FDA Approves Kymriah for Relapsed/Refractory Follicular Lymphoma

May 31st 2022, 1:59pm

Article

Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.

Experimental Lymphoma Drug Shows ‘Robust Clinical Activity,’ Researchers Say

February 25th 2022, 2:00pm

Article

Treatment with TRPH-222 led to lasting responses in certain patients with relapsed/refractory B-cell non-Hodgkin lymphomas, warranting a larger investigation into the drug, according to the researchers.

Kymriah Shows ‘Huge Potential’ for Patients With Heavily Pretreated, Relapsed Follicular Lymphoma

January 24th 2022, 7:59pm

Article

Kymriah may represent a more effective option than currently available treatments for patients with heavily pretreated follicular lymphoma, according to an expert from The University of Texas MD Anderson Cancer Center.

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23rd 2021, 8:00pm

Article

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

FDA Will Review New Drug to Treat Non-Hodgkin Lymphoma

November 1st 2021, 9:00pm

Article

The Food and Drug Administration will review parsaclisib for the treatment of patients with follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma.

FDA Speeds Up Review of CAR-T Cell Therapy to Treat Follicular Lymphoma

October 28th 2021, 7:00pm

Article

Kymriah was granted a priority review for the treatment of pretreated patients with relapsed or refractory follicular lymphoma.

When the Daughter of a Pediatric Oncologist Receives a Cancer Diagnosis

October 14th 2021, 3:00pm

Podcast

“We tried very hard, my daughter and I, to have a daughter-father relationship, not a daughter-doctor relationship,” said Dr. Michael Weiner on this episode of the “CURE® Talks Cancer” podcast, in which he discussed his career, his own cancer journey and his daughter’s diagnosis.

FDA Approves Yescarta for Third-Line Treatment of Relapsed or Refractory Follicular Lymphoma

March 6th 2021, 2:06am

Article

This accelerated FDA approval is the first CAR T-cell therapy approved for the treatment of patients with indolent follicular lymphoma.

Bringing Clinical Trials in Cancer Closer to Home

February 17th 2021, 8:00pm

Article

Local access to national cancer studies allows patients to receive promising new treatments in the most convenient setting possible: Their own community.